82 related articles for article (PubMed ID: 2544285)
1. Early studies with the novel 5-HT 1-like agonist GR43175 in healthy volunteers.
Fowler PA; Thomas M; Lacey LF; Andrew P; Dallas FA
Cephalalgia; 1989; 9 Suppl 9():57-62. PubMed ID: 2544285
[TBL] [Abstract][Full Text] [Related]
2. The kinetics of 14C-GR43175 in rat and dog.
Dallas FA; Dixon CM; McCulloch RJ; Saynor DA
Cephalalgia; 1989; 9 Suppl 9():53-6. PubMed ID: 2544284
[TBL] [Abstract][Full Text] [Related]
3. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine.
Perrin VL; Färkkilä M; Goasguen J; Doenicke A; Brand J; Tfelt-Hansen P
Cephalalgia; 1989; 9 Suppl 9():63-72. PubMed ID: 2544286
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute migraine with subcutaneous GR43175 in West Germany.
Baar HA; Brand J; Doenicke A; Melchart D; Lüben V; Tryba M; Sahlender HM
Cephalalgia; 1989; 9 Suppl 9():83-7. PubMed ID: 2544289
[TBL] [Abstract][Full Text] [Related]
5. Early clinical experience with subcutaneous GR43175 in acute migraine: an overview.
Tfelt-Hansen P; Brand J; Dano P; Doenicke A; Findley LJ; Iversen HK; Melchart D; Sahlender HM
Cephalalgia; 1989; 9 Suppl 9():73-7. PubMed ID: 2544287
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical experience with the use of subcutaneous GR43175 in treating acute migraine.
Brion N; Bons J; Plas J; Bayliss EM; Advenier C
Cephalalgia; 1989; 9 Suppl 9():79-82. PubMed ID: 2544288
[TBL] [Abstract][Full Text] [Related]
7. Effective improvement of symptoms in patients with acute migraine by GR43175 administered in dispersible tablets.
Doenicke A; Melchart D; Bayliss EM
Cephalalgia; 1989; 9 Suppl 9():89-92. PubMed ID: 2544290
[TBL] [Abstract][Full Text] [Related]
8. [Sumatriptan in the treatment of acute migraine attacks].
Diener HC
Internist (Berl); 1993 Jan; 34(1):63-6; discussion 66. PubMed ID: 8382666
[No Abstract] [Full Text] [Related]
9. The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan.
Fowler PA; Lacey LF; Thomas M; Keene ON; Tanner RJ; Baber NS
Eur Neurol; 1991; 31(5):291-4. PubMed ID: 1653135
[TBL] [Abstract][Full Text] [Related]
10. Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
Jansat JM; Costa J; Salvà P; Fernandez FJ; Martinez-Tobed A
J Clin Pharmacol; 2002 Dec; 42(12):1303-10. PubMed ID: 12463724
[TBL] [Abstract][Full Text] [Related]
11. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
[TBL] [Abstract][Full Text] [Related]
12. Treatment of migraine attacks with subcutaneous sumatriptan: first placebo-controlled study. The Subcutaneous Sumatriptan International Study Group.
Visser WH; Ferrari MD; Bayliss EM; Ludlow S; Pilgrim AJ
Cephalalgia; 1992 Oct; 12(5):308-13. PubMed ID: 1330318
[TBL] [Abstract][Full Text] [Related]
13. Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers.
Van Hecken AM; Depré M; De Schepper PJ; Fowler PA; Lacey LF; Durham JM
Br J Clin Pharmacol; 1992 Jul; 34(1):82-4. PubMed ID: 1321655
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute migraine with subcutaneous sumatriptan.
Cady RK; Wendt JK; Kirchner JR; Sargent JD; Rothrock JF; Skaggs H
JAMA; 1991 Jun; 265(21):2831-5. PubMed ID: 1851894
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and safety of oral almotriptan in healthy male volunteers.
McEwen J; Salva M; Jansat JM; Cabarrocas X
Biopharm Drug Dispos; 2004 Oct; 25(7):303-11. PubMed ID: 15386481
[TBL] [Abstract][Full Text] [Related]
16. Effect of sumatriptan, a new selective 5HT1-like agonist, on liquid gastric emptying in man.
Houghton LA; Fowler P; Keene ON; Read NW
Aliment Pharmacol Ther; 1992 Dec; 6(6):685-91. PubMed ID: 1336675
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.
Weber C; Schmitt R; Birnboeck H; Hopfgartner G; van Marle SP; Peeters PA; Jonkman JH; Jones CR
Clin Pharmacol Ther; 1996 Aug; 60(2):124-37. PubMed ID: 8823230
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic Properties of Nintedanib in Healthy Volunteers and Patients With Advanced Cancer.
Dallinger C; Trommeshauser D; Marzin K; Liesener A; Kaiser R; Stopfer P
J Clin Pharmacol; 2016 Nov; 56(11):1387-1394. PubMed ID: 27093880
[TBL] [Abstract][Full Text] [Related]
19. Single dose pharmacokinetics of sumatriptan in healthy volunteers.
Lacey LF; Hussey EK; Fowler PA
Eur J Clin Pharmacol; 1995; 47(6):543-8. PubMed ID: 7768259
[TBL] [Abstract][Full Text] [Related]
20. Lack of effect of GR43175 on peripheral arteries in man.
Nielsen TH; Tfelt-Hansen P
Cephalalgia; 1989; 9 Suppl 9():93-5. PubMed ID: 2544291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
